CASP1 and metabolic dysfunction-associated steatotic liver disease: Furthermore, caspase-1/11 can modulate the composition and diversity of the gut microbiota, thereby influencing hepatic lipid composition and metabolism, and facilitating the progression of NAFLD (De Sant Ana et al., 2020).